• Molecular NameGlatiramer Acetate
  • SynonymCOP-1; Copolymer-1; Copoylmer 1; glatiramer acetate
  • Weight623.657
  • Drugbank_IDDB05259
  • ACS_NO147245-92-9
  • Show 3D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)0.35
  • pkaN/A
  • LogD (pH=7, predicted)-1.06
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-1.35
  • LogSw (predicted, AB/LogsW2.0)11.6
  • Sw (mg/ml) (predicted, ACD/Labs)8.1
  • No.of HBond Donors0
  • No.of HBond Acceptors4
  • No.of Rotatable Bonds6
  • TPSA38.77
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyIt is a non-interferon and non steroidal medication.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityAdverse reactions include injection site reactions, vasodilatation, chest pain, asthenia, infection, pain, nausea, arthralgia, anxiety, and hypertonia.
  • LD50 (rat)N/A
  • LD50 (mouse)N/A